The purpose of our study was to assess the safety and use of liver biopsy in this patient population. Methods: In total, 1700 bone marrow transplants were performed at our institution from June ...

This Review summarizes current understanding of NAFLD, the evaluation of patients ... mellitus, hyperlipidemia and obesity. In response to the disadvantages of liver biopsy discussed above ...

In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more ...

Although all patients with NAFLD need aggressive management of cardiovascular risk factors, it is only patients with NASH who need treatment targeted at the liver disease. None of the currently ...

Of these patients, liver biopsy was performed in 154 patients at 36 weeks and in 134 patients at 96 weeks. At 36 weeks, a reduction in fibrosis without worsening of MASH occurred in 8 of 61 ...

Data regarding risk factors and long-term outcomes of U.S. patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. This study aimed to investigate ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical ...

Data regarding risk factors and long-term outcomes of U.S. patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. This study aimed to investigate ...

Dr. Andrews: A bone marrow biopsy and a ... of this illness, the patient had no history of recurrent fever or severe bacterial infections. He had hypertension, hyperlipidemia, and coronary artery ...

Agile scores had the highest predictive value and classified fewer patients ... associated steatotic liver disease and “may be suitable alternatives” to routine liver biopsy.

Late Breaking Poster Presentation Reports New Results Demonstrating Robust Liver Fat Reductions Across Key Subgroups, Including Patients with Type 2 Diabetes and Among Those with F2 or F3 Fibrosis ...